Veeva SiteVault allows sites to share and collaborate remotely with study monitors Veeva supporting industrywide drive to accelerate study execution BARCELONA, Spain \u2014 2 Apr, 2020<\/strong> – Veeva Systems<\/a> (NYSE: VEEV) today announced new remote monitoring capabilities in Veeva SiteVault for source document review and verification in clinical trials. Veeva SiteVault gives research sites a free eRegulatory application to efficiently manage study documentation and now with remote monitoring, allows study monitors to access, review, and collaborate on content online. Sites can centralize monitoring and communication with sponsors and CROs using a free system that is compliant with 21 CFR Part 11 and HIPAA requirements.<\/p>\n \u201cRemote monitoring supports the immediate need for sites and study monitors to continue working together while onsite visits have largely stopped,\u201d said Bree Burks, RN, MSN, vice president of site strategy at Veeva and a former clinical research director. \u201cVeeva SiteVault gives sites access to remote monitoring capabilities, at no cost, so they can keep running studies and treating patients.\u201d<\/p>\n SiteVault allows sites, sponsors, and CROs to remotely manage and track the workflow and downstream processes for source document review and verification. Sites and study monitors can easily view, comment, and respond to questions in a single, centralized system. Reporting, dashboards, and automatic notifications enable stakeholders to organize their tasks, get complete visibility into documents, and prioritize activities for immediate action.<\/p>\n Remote monitoring is available today in Veeva SiteVault. See a demo and learn more at sites.veeva.com\/RemoteMonitoring<\/a>.<\/p>\n What Sites are Saying About Remote Monitoring in Veeva SiteVault<\/strong><\/p>\n \u201cI\u2019m excited by what Veeva is doing to help the industry,\u201d said Trisha Locke, chief executive officer at Keystone Research. \u201cAs a high-volume ophthalmology site, we needed a solution that allows sponsors to access our study data. Veeva SiteVault gives us a free, compliant solution to manage regulatory documents and provide remote access to source information.\u201d<\/p>\n \u201cCOVID-19 has impacted our ability to see patients and monitors onsite,\u201d said William Chrvala, CCRC, managing director of Mid Hudson Medical Research, PLLC. \u201cVeeva SiteVault helps us quickly respond to changing business practices and focus on what matters most \u2013 our study participants.\u201d<\/p>\n \u201cThe ability to monitor studies remotely improves data quality and real-time responsiveness,\u201d said Amanda Wright, vice president of partnership development at Javara. \u201cSolutions like Veeva SiteVault can help sites improve engagement with sponsors and CROs.\u201d <\/p>\n About Veeva SiteVault<\/strong><\/p>\n Veeva SiteVault reduces the administrative burden of managing regulatory documents and processes for all trials with capabilities such as remote monitoring, electronic signatures, certified copy workflows, and reporting. For more information about Veeva SiteVault or to sign-up, visit sites.veeva.com<\/a>.<\/p>\n What Sites are Saying About Remote Monitoring in Veeva SiteVault<\/strong><\/p>\n \u201cI\u2019m excited by what Veeva is doing to help the industry,\u201d said Trisha Locke, chief executive officer at Keystone Research. \u201cAs a high-volume ophthalmology site, we needed a solution that allows sponsors to access our study data. Veeva SiteVault gives us a compliant solution to manage regulatory documents and provide remote access to source information.\u201d <\/p>\n \u201cCOVID-19 has impacted our ability to see patients and monitors onsite,\u201d said William Chrvala, CCRC, managing director of Mid Hudson Medical Research, PLLC. \u201cVeeva SiteVault helps us quickly respond to changing business practices and focus on what matters most \u2013 our study participants.\u201d<\/p>\n \u201cThe ability to monitor studies remotely improves data quality and real-time responsiveness,\u201d said Amanda Wright, vice president of partnership development at Javara. \u201cSolutions like Veeva SiteVault can help sites improve engagement with sponsors and CROs.\u201d <\/p>\n About Veeva SiteVault<\/strong><\/p>\n Veeva SiteVault reduces the administrative burden of managing regulatory documents and processes for all trials with capabilities such as remote monitoring, electronic signatures, certified copy workflows, and reporting. For more information about Veeva SiteVault or to sign-up, visit sites.veeva.com<\/a>.<\/p>\n Additional Information<\/strong> About Veeva Systems<\/strong> Forward-looking Statements<\/strong> ###<\/p>\n
\nfor source document review and verification
\n<\/em><\/p>\n
\nand improve trial quality across sites, sponsors, and CROs
\n<\/em><\/p>\n
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veeva_eu<\/a>
\nLike Veeva on Facebook: facebook.com\/veevasystems<\/a><\/p>\n
\nVeeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended January 31, 2020. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n